{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:55:09Z","timestamp":1781499309561,"version":"3.54.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by impairments in social communication and restricted, repetitive behaviors. Increasing evidence suggests that immune dysregulation may be present in a subset of individuals with neurodevelopmental disorders, although its role in ASD remains incompletely understood. We report two male patients with ASD, neurodevelopmental delay, immune dysregulation, and congenital cardiac anomalies. Genetic analysis using chromosomal microarray (CMA) identified distinct copy number variants on the X chromosome in each case. In patient 1, a duplication of the Xq28 region encompassing the\n                    <jats:italic>MECP2<\/jats:italic>\n                    gene was identified, consistent with MECP2 duplication syndrome, a well-established cause of neurodevelopmental impairment and recurrent infections. In this case, the clinical presentation was comparatively milder than typically described, highlighting phenotypic variability within this condition. In patient 2, a hemizygous deletion at Xp22.12 partially involving the\n                    <jats:italic>SH3KBP1<\/jats:italic>\n                    gene was detected and classified as a variant of uncertain significance (VUS). The patient presented with recurrent respiratory infections, impaired humoral immune responses, reduced B-cell counts, and neurodevelopmental impairment. This observation broadens the limited clinical spectrum associated with\n                    <jats:italic>SH3KBP1 v<\/jats:italic>\n                    ariants and may aid future assessment of their clinical relevance, although a causal relationship remains unproven. Together, these observations emphasize the value of comprehensive genetic testing in individuals with complex neurodevelopmental and systemic presentations and support consideration of immunological evaluation in selected patients with ASD who present with recurrent infections, allergic disease, or additional phenotypic features suggestive of inborn errors of immunity.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1814088","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:28:19Z","timestamp":1781497699000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: MECP2 and SH3KBP1 variants associated with autism spectrum disorder and immune dysregulation"],"prefix":"10.3389","volume":"17","author":[{"given":"Arnau","family":"Marin-Llobet","sequence":"first","affiliation":[{"name":"Pediatric Neurology Unit, Hospital General de Granollers","place":["Granollers, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hernando-Davalillo","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine\u2013Instituto Pedi\u00e1trico de Enfermedades Raras (IPER), Hospital Sant Joan de Deu","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidy","family":"Baide-Mairena","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Unit, Hospital General de Granollers","place":["Granollers, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Llobet-Agullo","sequence":"additional","affiliation":[{"name":"Pediatric Allergy and Clinical Immunology Unit, Hospital General de Granollers","place":["Granollers, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Fornes Garcia","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine\u2013Instituto Pedi\u00e1trico de Enfermedades Raras (IPER), Hospital Sant Joan de Deu","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Perez-Herrera","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology Unit, Hospital General de Granollers","place":["Granollers, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Baro-Serrano","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Unit, Hospital General de Granollers","place":["Granollers, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"B1","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13505","article-title":"Time trends in autism diagnosis over 20 years: a UK population-based cohort study","volume":"63","author":"Russell","year":"2022","journal-title":"J Child Psychol Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","article-title":"Prevalence and characteristics of autism spectrum disorder among children aged 8 years\u2014Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020","volume":"72","author":"Maenner","year":"2023","journal-title":"MMWR Surveill Summ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s11689-018-9238-9","article-title":"A genome-wide linkage study of autism spectrum disorder and the broad autism phenotype in extended pedigrees","volume":"10","author":"Woodbury-Smith","year":"2018","journal-title":"J Neurodev Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12499","article-title":"Heritability of autism spectrum disorders: a meta-analysis of twin studies","volume":"57","author":"Tick","year":"2016","journal-title":"J Child Psychol Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2017.4","article-title":"Autism genetics: opportunities and challenges for clinical translation","volume":"18","author":"Vorstman","year":"2017","journal-title":"Nat Rev Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01148-2","article-title":"Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes","volume":"54","author":"Zhou","year":"2022","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100172","DOI":"10.1016\/j.xhgg.2022.100150","article-title":"Structural variants identified using non-Mendelian inheritance patterns advance the mechanistic understanding of autism spectrum disorder","volume":"4","author":"Kainer","year":"2023","journal-title":"Hum Genet Genomics Adv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13229-019-0287-z","article-title":"A meta-analysis of two high-risk prospective cohort studies reveals autism-specific transcriptional changes to chromatin, autoimmune and environmental response genes in umbilical cord blood","volume":"10","author":"Mordaunt","year":"2019","journal-title":"Mol Autism"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218290","article-title":"An overview of the main genetic, epigenetic and environmental factors involved in autism spectrum disorder focusing on synaptic activity","volume":"21","author":"Masini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2385117","article-title":"The early life exposome and autism risk: a role for the maternal microbiome","volume":"16","author":"Di Ges\u00f9","year":"2024","journal-title":"Gut Microbes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22044","article-title":"Immune system gene dysregulation in autism and schizophrenia","volume":"72","author":"Michel","year":"2012","journal-title":"Dev Neurobiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2015.00121","article-title":"The impact of neuroimmune alterations in autism spectrum disorder","volume":"6","author":"Gottfried","year":"2015","journal-title":"Front Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00329","article-title":"The interaction between the immune system and epigenetics in the etiology of autism spectrum disorders","volume":"10","author":"Nardone","year":"2016","journal-title":"Front Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0822-x","article-title":"Immune abnormalities in autism spectrum disorder\u2014Could they hold promise for causative treatment","volume":"55","author":"G\u0142adysz","year":"2018","journal-title":"Mol\u00a0Neurobiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1006612","article-title":"Re-emerging concepts of immune dysregulation in autism spectrum disorders","volume":"13","author":"Erbescu","year":"2022","journal-title":"Front Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-023-00656-z","article-title":"Inborn errors of immunity: an expanding universe of disease and genetic architecture","volume":"25","author":"Akalu","year":"2024","journal-title":"Nat Rev Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.20517\/jtgg.2023.32","article-title":"Inborn errors of immunity present with neuropsychiatric symptoms overlapping with autistic behavioral symptoms","volume":"7","author":"Jyonouchi","year":"2023","journal-title":"J Transl Genet Genom"},{"key":"B20","article-title":"Inborn errors of immunity in paediatric neurology","volume":"37","author":"Smuts","year":"2024","journal-title":"Curr Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.023","article-title":"The relevance of primary immunodeficiency registries on a global perspective","volume":"148","author":"Condino-Neto","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav Immun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v12.i3.172","article-title":"Viruses and autism: a bi-mutual cause and effect","volume":"12","author":"Al-Beltagi","year":"2023","journal-title":"World J Virol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00011","article-title":"Distinct cytokine and chemokine profiles in autism spectrum disorders","volume":"8","author":"Han","year":"2017","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21951","article-title":"Autism in a child with X-linked agammaglobulinemia","volume":"14","author":"Bied","year":"2022","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063033","article-title":"Immune dysregulation in autism spectrum disorder: what do we know about it","volume":"23","author":"Robinson-Agramonte","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22420","article-title":"Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the Optilite automated turbidimetric analyzer","volume":"32","author":"Garcia-Prat","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22520","article-title":"Lymphocyte subsets reference values in childhood","volume":"87","author":"Tosato","year":"2015","journal-title":"Cytometry A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jim.2018.08.002","article-title":"Measuring immune responses to pneumococcal vaccines","volume":"461","author":"LaFon","year":"2018","journal-title":"J\u00a0Immunol Methods"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00586","article-title":"Specific antibody deficiency: controversies in diagnosis and management","volume":"8","author":"Perez","year":"2017","journal-title":"Front Immunol"},{"key":"B33","unstructured":"Diagnostic criteria for primary immunodeficiencies"},{"key":"B34","unstructured":""},{"key":"B35","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-023-01071-4","article-title":"Chromosome 22q11.2 deletion (DiGeorge syndrome): immunologic features, diagnosis, and management","volume":"23","author":"Biggs","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"B37","unstructured":""},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-013-1796-9","article-title":"The MECP2 duplication syndrome","author":"Ramocki","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179610","article-title":"MECP2-related disorders in males","volume":"22","author":"Pascual-Alonso","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-022-02278-w","article-title":"A brief history of MECP2 duplication syndrome: 20-years of clinical understanding","volume":"17","author":"Ta","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13521","article-title":"Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome","volume":"95","author":"Peters","year":"2019","journal-title":"Clin Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13023-025-04008-4","article-title":"Functional skills in MECP2 duplication syndrome: developmental dynamics and regression","volume":"21","author":"Ta","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15010010","article-title":"MECP2 duplication syndrome: AI-based diagnosis, severity scale development and correlation with clinical and molecular variables","volume":"15","author":"Vega-Hanna","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B44","unstructured":"Dosage sensitivity curation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0129-5","article-title":"Infectious and immunologic phenotype of MECP2 duplication syndrome","volume":"35","author":"Bauer","year":"2015","journal-title":"J\u00a0ClinImmunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1389483\/v1","article-title":"IRAK1 duplication in MECP2 duplication syndrome does not increase canonical NF-\u03baB-induced inflammation","volume":"43","author":"Gottschalk","year":"2023","journal-title":"J ClinImmunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.251","article-title":"The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85","volume":"30","author":"Oellerich","year":"2011","journal-title":"EMBO J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.912826","article-title":"B- and T-cell subset abnormalities in monogenic common variable immunodeficiency","volume":"13","author":"Fekrvand","year":"2022","journal-title":"Front Immunol"},{"key":"B49","unstructured":"Johns hopkins university, baltimore, MD. Immunodeficiency 61; IMD61. MIM #300310"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170534","article-title":"Germline deletion of CIN85 in humans with X chromosome-linked antibody deficiency","volume":"215","author":"Keller","year":"2018","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.54","article-title":"Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia","volume":"16","author":"Piton","year":"2011","journal-title":"Mol Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/gim.0b013e31822c79f9","article-title":"An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities","volume":"13","author":"Kaminsky","year":"2011","journal-title":"Genet Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1497921","article-title":"Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation","volume":"15","author":"Cortesi","year":"2024","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.lanepe.2024.100907","article-title":"Diagnosis of common health conditions among autistic adults in the UK: evidence from a matched cohort study","volume":"41","author":"O'Nions","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-00993-x","article-title":"Immunoregulatory and\/or anti-inflammatory agents for the management of core and associated symptoms in individuals with autism spectrum disorder: a narrative review of randomized, placebo-controlled trials","volume":"37","author":"Arteaga-Henr\u00edquez","year":"2023","journal-title":"CNS Drugs"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060488","article-title":"A systematic review and meta-analysis of immunoglobulin G abnormalities and the therapeutic use of intravenous immunoglobulins (IVIG) in autism spectrum disorder","volume":"11","author":"Rossignol","year":"2021","journal-title":"J Pers Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1814088\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:28:26Z","timestamp":1781497706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1814088\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2026.1814088"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1814088","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1814088"}}